Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for biologics
3.2.1.2 Rising adoption of CDMOs for outsourcing manufacturing activities
3.2.1.3 Rising investments in R&D
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of manufacturing
3.2.2.2 Quality control challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Oncology agents
5.3 Insulins
5.4 Immunostimulating and immunosuppressive agents
5.5 Autoimmune
5.6 Interferons
5.7 Vaccines
5.8 Blood coagulation factors
5.9 Growth hormones
5.10 Other types
Chapter 6 Market Estimates and Forecast, By Source, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Mammalian
6.3 E. coli
6.4 S. cerevisiae
6.5 Other sources
Chapter 7 Market Estimates and Forecast, By Therapeutic Area, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Oncology
7.3 Metabolic disorders
7.4 Immunological disorders
7.5 Infectious diseases
7.6 Hematological disorders
7.7 Women health
7.8 Other therapeutic areas
Chapter 8 Market Estimates and Forecast, By Service Type, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Contract manufacturing
8.3 Contract development
Chapter 9 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical companies
9.3 Biotechnology companies
9.4 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Batavia Biosciences B.V.
11.2 BIOVIAN
11.3 Catalent, Inc
11.4 Curia Global, Inc.
11.5 Enzene Biosciences Ltd
11.6 FUJIFILM Diosynth Biotechnologies
11.7 HALIX B.V.
11.8 Lonza
11.9 Richter-Helm BioLogics
11.10 WuXi Biologics
